AUTONOMIX MEDICAL INC. - COMMON STOCK

Autonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” Segment

03 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire

Autonomix Announces Positive Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial

18 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire

Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive Officer

17 июн 2024 15:05:00 Источник Nasdaq GlobeNewswire

Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024

10 июн 2024 07:00:00 Источник Nasdaq GlobeNewswire

Autonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical Trial

03 июн 2024 07:15:00 Источник Nasdaq GlobeNewswire

Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update

31 май 2024 07:05:00 Источник Nasdaq GlobeNewswire

Autonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic Cancer

23 май 2024 08:15:00 Источник Nasdaq GlobeNewswire

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

14 май 2024 15:15:00 Источник Nasdaq GlobeNewswire

Autonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary Microchip

25 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire

Autonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

24 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire

Autonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related Pain

16 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire

Autonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal Denervation

09 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire

Autonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX Ticker

08 апр 2024 07:30:00 Источник Nasdaq GlobeNewswire

Autonomix to Present at the MedInvest Biotech & Pharma Investor Conference

27 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire

 Autonomix (NASDAQ: AMIX) to Present at the Benzinga Virtual Healthcare Summit 2024

20 мар 2024 07:05:00 Источник Nasdaq GlobeNewswire

Autonomix Appoints Jennifer Cook as Chief Business Officer

19 мар 2024 07:45:00 Источник Nasdaq GlobeNewswire

Autonomix Completes First Three Patient Procedures in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

14 мар 2024 07:15:00 Источник Nasdaq GlobeNewswire

Autonomix Enrolls First Patients in Human Clinical Trial Targeting Multi-Billion-Dollar Pancreatic Cancer Market

06 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire

Autonomix Signs Key Clinical Agreements in Preparation to Begin March 2024 Human Clinical Trial

29 фев 2024 07:30:00 Источник Nasdaq GlobeNewswire

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity

23 фев 2024 07:50:00 Источник Nasdaq GlobeNewswire